Education
About Us
Working with TipRanks
Follow Us
Shantharam Harish Insider Profile
4 Followers
Shantharam Harish, CFO at CymaBay Therapeutics, holds 75.00K shares in ALX Oncology Holdings (Ticker: ALXO), holds 0.00 shares in CymaBay Therapeutics (Ticker: CBAY). Most recently, Shantharam Harish Bought ― shares of ALX Oncology Holdings on Aug 20, 2025 for an estimated value of $57.75K.
Shantharam Harish CymaBay Therapeutics (CBAY)CFO
CymaBay Therapeutics (CBAY)
CFO
Not Ranked
Shantharam Harish has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Shantharam Harish's holdings
Insider Roles
CFO
Roles that Shantharam Harish holds in companies
Most Profitable Insider Trade
The most profitable trade made by Shantharam Harish
Shantharam Harish's Trading History
CymaBay Therapeutics
Mar 22, 2024
―
Uninformative Sell
―
$0.00
ALX Oncology Holdings
Aug 20, 2025
CFO
Informative Buy
57.75K
$82.50K
List of latest transactions for each holding click on a transaction to see Shantharam Harish's performance on stock
You May Also Like
Shantharam Harish insider profile FAQ
What is the percentage of profitable transactions made by Shantharam Harish?
The percentage of profitable transactions made by Shantharam Harish is ―.
What is the average return per transaction made by Shantharam Harish?
The average return per transaction made by Shantharam Harish is ―.
What stocks does Shantharam Harish hold?
Shantharam Harish holds: CBAY, ALXO stocks.
What was Shantharam Harish’s latest transaction?
Shantharam Harish latest transaction was an Informative Buy of $57.75K.
What was Shantharam Harish's most profitable transaction?
Shantharam Harish’s most profitable transaction was an Informative Buy of ALXO stock on August 20, 2025. The return on the trade was 40.60%.
What is Shantharam Harish's role in CymaBay Therapeutics?
Shantharam Harish's role in CymaBay Therapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.